87 related articles for article (PubMed ID: 8303978)
21. [The composition of fatty acids in individual classes of blood platelet phospholipids of patients with uremia].
Krawczyk W; Dmoszyńska A; Ledwozyw A
Pol Arch Med Wewn; 1993 May; 89(5):377-84. PubMed ID: 8367371
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of treating anemia in patients undergoing chronic dialysis with small doses of human recombinant erythropoietin].
Marusza W; Matuszkiewicz-Rowińska J; Tomik Z; Andrzejewski A; Rokicka M; Paszkowska M; Drygieniec D; Bobilewicz D; Zawadzka M; Abbas-Fatah A
Pol Tyg Lek; 1995 Oct; 50(40-44):15-8, 31. PubMed ID: 8650050
[TBL] [Abstract][Full Text] [Related]
23. Effect of subcutaneous administration of recombinant human erythropoietin on plasma protein C, protein S, and antithrombin III levels in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Yin JA; Li PK; Yuen PM; Lui SF
Int J Artif Organs; 1992 May; 15(5):264-8. PubMed ID: 1601509
[TBL] [Abstract][Full Text] [Related]
24. Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin.
Małyszko JS; Małyszko J; Pawlak K; Pawlak D; Buczko W; Myśliwiec M
Nephron; 2000 Apr; 84(4):305-11. PubMed ID: 10754406
[TBL] [Abstract][Full Text] [Related]
25. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
Aguilera A; Bajo MA; Díez JJ; Ruiz-Caravaca ML; Vicenta Cuesta M; Alvarez V; Codoceo R; Selgas R
Adv Perit Dial; 2002; 18():200-5. PubMed ID: 12402619
[TBL] [Abstract][Full Text] [Related]
26. [Effect of erythropoietin therapy on serum lipoprotein levels in patients on hemodialysis].
Kes P; Bobić I; Reiner Z; Ratković-Gusić I
Lijec Vjesn; 2002 May; 124(5):146-50. PubMed ID: 12152415
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
Qureshi IZ; Abid K; Ambreen F; Qureshi AL
Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
[TBL] [Abstract][Full Text] [Related]
28. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
[TBL] [Abstract][Full Text] [Related]
29. Association between erythropoietin requirements and antihypertensive agents.
Yano S; Suzuki K; Iwamoto M; Urushidani Y; Yokogi H; Kusakari M; Aoki A; Sumi M; Kitamura K; Sanematsu H; Gohbara M; Imamura S; Sugimoto T
Nephron Clin Pract; 2008; 109(1):c33-9. PubMed ID: 18506108
[TBL] [Abstract][Full Text] [Related]
30. Intravenous iron attenuates postvaccination anti-HBsAg titres after quadruple hepatitis B vaccination in dialysis patients with erythropoietin therapy.
Liu JH; Liu YL; Lin HH; Yang YF; Kuo HL; Lin PW; Huang CC
Int J Clin Pract; 2009 Mar; 63(3):387-93. PubMed ID: 18410348
[TBL] [Abstract][Full Text] [Related]
31. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
[TBL] [Abstract][Full Text] [Related]
32. Influence of long-term erythropoietin treatment on plasma levels of calcium-phosphate related hormones in haemodialyzed uraemic patients.
Kokot F; Wiecek A; Marcinkowski W; Schmidt-Gayk H; Rudka R; Trembecki J
Ann Univ Mariae Curie Sklodowska Med; 1994; 48 Suppl 3():9-16. PubMed ID: 8192535
[TBL] [Abstract][Full Text] [Related]
33. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin.
Bárány P; Pettersson E; Konarski-Svensson JK
Nephrol Dial Transplant; 1993; 8(5):426-32. PubMed ID: 8393547
[TBL] [Abstract][Full Text] [Related]
34. Platelet intracellular calcium is not modified by subcutaneous administration of erythropoietin.
Lo Cascio C; Guzzo P; Loschiavo C; Manzato F; Lechi C
Thromb Haemost; 1994 Aug; 72(2):326-7. PubMed ID: 7831674
[No Abstract] [Full Text] [Related]
35. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
Reuter SE; Faull RJ; Ranieri E; Evans AM
Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of recombinant human erythropoietin treatment of anaemia associated with multiple myeloma in haemodialysed patients.
Ruedin P; Pechère Bertschi A; Chapuis B; Benedet P; Leski M
Nephrol Dial Transplant; 1993; 8(4):315-8. PubMed ID: 8390005
[TBL] [Abstract][Full Text] [Related]
37. [Improvement of sexual function in hemodialyzed male patients with chronic renal failure treated with erythropoietin (rHuEPO)].
Trembecki J; Kokot F; Wiecek A; Marcinkowski W; Rudka R
Przegl Lek; 1995; 52(9):462-6. PubMed ID: 8834648
[TBL] [Abstract][Full Text] [Related]
38. Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats.
Soni HM; Vekaria AM; Rath AC; Belemkar S; Jain MR
Indian J Pharmacol; 2014; 46(3):328-33. PubMed ID: 24987182
[TBL] [Abstract][Full Text] [Related]
39. [The phospholipid spectrum of the blood serum in patients with chronic non-specific pulmonary diseases during rehabilitation treatment].
Ivanov EM; Novgorodtseva TP; Endakova EA; Svetashev VI
Ter Arkh; 1989; 61(3):94-7. PubMed ID: 2741128
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human erythropoietin resistance in hemodialysis. Effects of paired filtration dialysis.
Carozzi S; Nasini MG; Santoni O; Tirotta A; Sanna A
ASAIO J; 1997; 43(5):M535-8. PubMed ID: 9360100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
